About MSHO

Sponsors

Premier Plus Sponsor

Premier Sponsor

Champion Sponsor

Champion Sponsor

Champion Sponsor

Premier Sponsor

Premier Sponsor

Agios Pharmaceuticals

Emerging Sponsor

Champion Sponsor

Champion Sponsor

Emerging Sponsor

Premier Plus Sponsor

Supporting Sponsor

Champion Sponsor

Emerging Sponsor

Champion Sponsor

Champion Sponsor

Seattle Genetics

Champion Sponsor

Pharmacy Advantage

Supporting Sponsor

Champion Sponsor

Supporting Sponsor

Champion Sponsor

Champion Sponsor

Premier Sponsor

Champion Sponsor

Premier Sponsor

Premier Sponsor

Premier Sponsor

Champion Sponsor

Champion Sponsor

Premier Sponsor

Premier Plus Sponsor

Champion Sponsor

Champion Sponsor

Champion Sponsor

Premier Sponsor

Supporting Sponsor

Premier Sponsor

Champion Sponsor

Premier Plus Sponsor

Premier Plus Sponsor

Supporting Sponsor

Premier Sponsor

Oncology Supply

Premier Sponsor

Premier Plus Sponsor

Premier Sponsor

view all sponsors

Advocacy

MSHO continuously contacts legislators, provides comments to policy makers and collaborates with payers on issues of concern to those delivering care to cancer patients.

Education

It is important that our members are aware of meetings, web casts, and other educational opportunities specifically designed to address the complexities of cancer care.

Research

MSHO is committed to furthering the advancement of cancer care by supporting the many organizations that provide cancer clinical trials to Michigan’s cancer patients.

Latest News

UPDATED Opioid Laws FAQ's

Changes made to Start Talking Form, MAPS Registration & Use and Acute Pain

The Centers for Medicare & Medicaid Services (CMS) is seeking public comments in June on two initiatives that have important ramifications for CAR T-cell therapies.

Comments Due by June 25

MAPS and NarxCare Video Tutorials

Created to assist current and future MAPS users on navigating the system and understanding the data contained within the MAPS reports.

June 1 Deadline for New Prescribing Requirements

Are You Ready?

Need Help Understanding Michigan's Opioid Prescribing Bills?

LARA has compiled a list of Frequently Asked Questions

National Comprehensive Cancer Network (NCCN)

CMS Releases Updated 2018 Merit-Based Incentive Payment System Participation Lookup Tool

Clinicians can now use the updated Participation Lookup Tool from the Centers for Medicare & Medicaid Services (CMS) to check their 2018 eligibility for the Merit-Based Incentive Payment System (MIPS)

House Bill 5678 Passed the House and Senate

New requirements regarding MAPS and bona fide prescriber/patient relationship

USP 797 Revision Timeline Released

Lt. Gov. Brian Calley signs legislation to combat opioid epidemic, prevent addiction in Michigan

Register Today for The Annual Review of the American Society of Hematology Meeting

Saturday, January 27 at the Dearborn Inn in Dearborn

Will Foundation’s FDA, CMS Nod Help Cancer DNA Tests Break Through

December 1st, 2017, Xconomy

Message from the MSHO President

Why we must Advocate

2018 Medicare Physician Fee Schedule Proposed Rule Released

To help patients deal with the rising costs of cancer care, the Association of Community Cancer Centers has launched a Financial Advocacy Boot Camp for healthcare providers.

Medicare Part B Resources

Review ACCCs Medicare Part B Slide Deck Here